Amneal Pharmaceuticals reported a gross margin of 42.01% and a net margin of 8.74% for the quarter ended Jun 2026. These financial ratios cover 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||
| Gross Margin | 37.55% | 30.99% | 35.08% | 35.85% | 35.60% | 35.32% | 31.96% | 36.73% | 37.50% | 30.77% | 36.11% | 35.62% | 38.37% | 35.98% | 36.80% | 39.51% | 34.92% | 36.50% | 44.31% | 42.01% | |||||||||||||||||
| EBT Margin | -0.39% | -3.04% | -1.99% | -41.61% | 0.40% | -1.26% | -1.69% | 4.95% | 3.70% | -13.53% | -11.46% | 2.91% | 2.20% | -2.10% | 5.39% | 7.14% | -0.67% | 6.78% | 11.10% | 8.92% | |||||||||||||||||
| EBIT Margin | 5.39% | 2.08% | 4.68% | -35.51% | 8.13% | 5.91% | 6.18% | 13.37% | 12.20% | 2.30% | -1.63% | 13.60% | 12.64% | 10.38% | 14.43% | 15.37% | 8.97% | 13.76% | 19.62% | 16.30% | |||||||||||||||||
| EBITDA Margin | 5.39% | 2.08% | 4.68% | -35.51% | 8.13% | 5.91% | 6.18% | 13.37% | 12.20% | 2.30% | -1.63% | 13.60% | 12.64% | 10.38% | 14.43% | 15.37% | 8.97% | 13.76% | 19.62% | 16.30% | |||||||||||||||||
| Operating Margin | 5.39% | 2.08% | 4.68% | -35.51% | 8.13% | 5.91% | 6.18% | 13.37% | 12.20% | 2.30% | -1.63% | 13.60% | 12.64% | 10.38% | 14.43% | 15.37% | 8.97% | 13.76% | 19.62% | 16.30% | |||||||||||||||||
| Net Margin | -0.80% | -1.19% | -0.43% | -21.60% | -0.49% | -0.71% | -1.25% | 1.99% | 1.56% | -15.99% | -12.39% | 2.39% | 1.67% | -2.84% | 3.54% | 4.92% | 2.31% | 6.09% | 10.80% | 8.74% | |||||||||||||||||
| FCF Margin | 13.57% | 8.52% | 22.01% | -23.34% | 13.65% | -5.70% | 23.32% | -3.90% | 11.25% | 20.42% | -2.06% | 4.14% | 17.77% | 14.09% | -0.83% | 8.42% | 13.53% | 13.33% | -4.83% | -6.52% | |||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 521.82M | 504.82M | 500.81M | 522.63M | 538.44M | 537.30M | 529.89M | 539.80M | 563.52M | 578.93M | 576.02M | 573.14M | 585.99M | 604.41M | 606.94M | 605.20M | 611.74M | 610.40M | 623.96M | 659.79M | |||||||||||||||||
| Assets AverageAssets Avg. | 3,998.73M | 3,957.04M | 3,914.32M | 3,965.19M | 3,957.72M | 3,836.69M | 3,712.97M | 3,663.75M | 3,693.98M | 3,579.82M | 3,464.48M | 3,483.16M | 3,485.45M | 3,481.21M | 3,433.35M | 3,394.02M | 3,511.33M | 3,639.08M | 3,609.25M | 3,658.28M | |||||||||||||||||
| Invested CapitalInvested Cap. | 3,133.78M | 3,156.11M | 3,126.55M | 2,935.26M | 2,895.31M | 2,868.40M | 2,841.11M | 2,850.35M | 2,802.58M | 2,619.14M | 2,526.74M | 2,601.76M | 2,525.42M | 2,500.70M | 2,343.77M | 2,355.05M | 2,470.95M | 2,507.31M | 2,531.99M | 2,703.32M | |||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.52 | 0.53 | 0.54 | 0.54 | 0.54 | 0.58 | 0.61 | 0.63 | 0.65 | 0.67 | 0.72 | 0.75 | 0.77 | 0.80 | 0.82 | 0.84 | 0.84 | 0.83 | 0.84 | 0.85 | |||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.69 | 0.71 | 0.70 | 0.68 | 0.70 | 0.71 | 0.75 | 0.73 | 0.72 | 0.75 | 0.75 | 0.76 | 0.76 | 0.75 | 0.74 | 0.72 | 0.72 | 0.70 | 0.73 | 0.71 | |||||||||||||||||
| Dividends & Payouts | |||||||||||||||||||||||||||||||||||||
| Dividend Coverage RatioDiv. Cover | |||||||||||||||||||||||||||||||||||||
| FCF Payout RatioFCF Cover | |||||||||||||||||||||||||||||||||||||
| Dividend YieldDiv. Yield | |||||||||||||||||||||||||||||||||||||
| Payout Ratio | |||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -379.97 | -226.49 | -585.83 | -7.99 | -228.02 | -139.44 | -61.15 | 79.64 | 133.58 | -18.86 | -22.90 | 117.09 | 219.27 | -118.36 | 106.69 | 71.35 | 173.55 | 79.97 | 50.84 | 79.41 | |||||||||||||||||
| Price to SalesP/S | 3.05 | 2.69 | 2.54 | 1.73 | 1.12 | 0.99 | 0.76 | 1.58 | 2.09 | 3.02 | 2.84 | 2.80 | 3.67 | 3.36 | 3.78 | 3.51 | 4.01 | 4.87 | 5.49 | 6.94 | |||||||||||||||||
| Price to BookP/B | 4.20 | 3.94 | 3.10 | 5.58 | 3.16 | 3.28 | 3.15 | 6.30 | 8.39 | 92.96 | -29.40 | -34.19 | -27.55 | -22.42 | -19.90 | -22.58 | -28.62 | -55.58 | -86.26 | 167.39 | |||||||||||||||||
| Enterprise Value | 1,322.55M | 1,213.45M | 1,069.00M | 891.12M | 548.20M | 603.15M | 307.43M | 871.94M | 1,243.49M | 1,809.98M | 1,870.93M | 1,975.25M | 2,563.79M | 2,409.36M | 2,639.88M | 2,535.16M | 3,013.30M | 3,759.59M | 3,853.71M | 5,484.34M | |||||||||||||||||
| EV to EBIT | 46.38 | 108.59 | 45.87 | -4.49 | 12.36 | 16.74 | 8.92 | 10.89 | 16.44 | 127.53 | -174.10 | 20.69 | 28.87 | 31.79 | 26.31 | 22.76 | 42.84 | 33.56 | 27.18 | 42.26 | |||||||||||||||||
| EV to EBITDA | 46.38 | 108.59 | 45.87 | -4.49 | 12.36 | 16.74 | 8.92 | 10.89 | 16.44 | 127.53 | -174.10 | 20.69 | 28.87 | 31.79 | 26.31 | 22.76 | 42.84 | 33.56 | 27.18 | 42.26 | |||||||||||||||||
| Market Capitalization | 1,609.95M | 1,444.33M | 1,263.06M | 965.21M | 613.16M | 604.18M | 424.58M | 949.12M | 1,293.27M | 1,860.23M | 1,870.43M | 1,965.60M | 2,577.91M | 2,454.93M | 2,626.46M | 2,540.90M | 3,146.77M | 3,964.33M | 3,965.45M | 5,528.02M | |||||||||||||||||
| Price to FCFP/FCF | 22.45 | 31.56 | 11.53 | -7.39 | 8.23 | -17.38 | 3.27 | -40.65 | 18.55 | 14.77 | -137.45 | 67.71 | 20.65 | 23.85 | -456.46 | 41.66 | 29.64 | 36.52 | -113.56 | -106.43 | |||||||||||||||||
| EV to FCF | 18.44 | 26.52 | 9.76 | -6.82 | 7.36 | -17.35 | 2.36 | -37.35 | 17.83 | 14.37 | -137.49 | 68.04 | 20.54 | 23.41 | -458.79 | 41.57 | 28.39 | 34.64 | -110.36 | -105.59 | |||||||||||||||||
| EV to CFO | 16.06 | 19.18 | 8.88 | -7.10 | 5.86 | -25.90 | 2.20 | -76.86 | 15.28 | 13.33 | -424.25 | 49.81 | 18.08 | 20.40 | 356.36 | 30.25 | 25.44 | 28.85 | -144.10 | -258.16 | |||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 5.39% | 2.08% | 4.68% | -35.51% | 8.13% | 5.91% | 6.18% | 13.37% | 12.20% | 2.30% | -1.63% | 13.60% | 12.64% | 10.38% | 14.43% | 15.37% | 8.97% | 13.76% | 19.62% | 16.30% | |||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 4.85% | 4.66% | 3.93% | -4.56% | -3.82% | -3.08% | -2.78% | 6.75% | 7.71% | 7.48% | 6.05% | 7.37% | 7.85% | 10.60% | 15.29% | 16.46% | 13.51% | 14.29% | 15.12% | 16.36% | |||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 4.08% | 3.13% | -0.45% | -4.68% | -4.31% | -3.38% | -3.06% | 5.24% | 8.73% | 9.12% | 7.00% | 7.84% | 8.71% | 13.32% | 8.32% | 9.19% | 12.45% | 14.55% | 17.23% | 18.56% | |||||||||||||||||
| Return on Assets [ROA]ROA | 0.84% | 0.51% | -0.02% | -6.89% | -6.81% | -6.64% | -6.96% | 0.31% | 1.05% | -1.36% | -3.47% | -3.82% | -4.20% | -2.12% | 0.94% | 1.51% | 1.64% | 3.52% | 5.02% | 5.89% |